An Open-label Extension of Study M15-736 to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease.

  • Bertram, Kelly (Primary Chief Investigator (PCI))
  • Burn, Katherine (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date20/10/20 → 31/12/24

Keywords

  • Neuroscience
  • Parkinson's disease
  • Clinical trial